Both published and our own data revealed that genetic alterations, including losses of TP53 and CDKN2A (p16), and amplification of MYC, were highly recurrent in human NPC patients, indicating these alterations might promote NPC tumorigenesis (Figure 2F). Here, CDKN2A is linked to nasopharyngeal carcinoma.